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Abstract. Nipple‑sparing mastectomies (NSMs) are increasingly used in the surgical treatment of patients with breast
cancer and for prevention of breast cancer. The present study
was performed to review the outcomes of patients undergoing
NSMs at a single large university setting. A retrospective
chart review was performed on all patients undergoing NSMs
from 2008‑2014. Charts were reviewed for demographic
data and patient characteristics. Tumor and breast size,
cancer recurrence and complications were also evaluated.
Descriptive statistics were utilized to summarize the findings. From 2008‑2014, 110 patients underwent 197 NSMs.
The mean patient age was 44.4 years (range, 20‑77). The
average body mass index was 24 (range, 18‑47). Breast weight
was available for 106 specimens, with a mean weight of
475.5 g (range, 124.1‑1,625.0 g). Seventy‑three NSMs were
performed for cancer and 124 were performed prophylactically. The mean tumor width was 1.38 cm (range, 0‑6.0 cm),
with an average nipple to tumor distance of 5.87 cm (range,
2.93‑10.0 cm). Three (4%) patients required removal of the
nipple areolar complex (NAC) due to pathological extension
of the tumor. A total of 34 (17.2%) complications occurred,
including infections, hematomas and nipple necrosis, with
9 requiring removal of the NAC and 13 requiring removal
of the tissue expander or implant. Smokers had a 36.0%
(9/25) complication rate, compared with 14.5% (25/172) of
nonsmokers (P<0.05). During follow‑up, one recurrence was
noted, located on the chest wall. There were no recurrences
in the NAC group. Therefore, NSMs may safely be performed
without compromising oncologic outcomes or increasing
complication rates in properly selected patients.
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Introduction
For nearly a century the standard surgical approach to
treating breast cancer was to perform a Halstead radical
mastectomy removing the breast, axillary lymph nodes and
pectoralis muscle. It was believed that the more tissue that was
removed the better the survival for the patient. This theory
was disproven and surgeons began performing less invasive
surgery in the 1970s and 1980s (1,2). With the publication of
National Surgical Adjuvant Breast and Bowel Project protocol
B‑06, breast conserving surgery was determined to have
equivalent results in terms of survival and local recurrence
with the addition of radiation therapy, when compared with
mastectomy (3). If deemed to be an appropriate candidate,
patients have the choice between breast conserving surgery
or mastectomy. The rates of breast conserving surgery have
remained stable over the last decade, however the rates of
women opting for contralateral prophylactic mastectomy
have steadily increased for various reasons (4). For patients
undergoing mastectomies, rates of reconstruction vary and
≤42% undergo this procedure (5). Traditionally, mastectomy
with reconstruction for the treatment of breast cancer has been
performed via a skin‑sparing approach, as first described by
Toth and Lappert (6) in 1991. Nipple and skin‑sparing mastectomies, with preservation of the nipple‑areola complex (NAC),
have generally been performed for the treatment of benign
disease and prophylactically in women at high risk for the
development of breast cancer (7‑9).
One of the concerns regarding the safety of nipple‑sparing
mastectomies (NSMs) in the treatment of breast cancer
patients is the potential increased risk of breast cancer recurrence. The terminal duct lobular unit has been identified as
the location for the development of all breast cancer, and a
2008 study identified the presence of terminal duct lobular
units in the nipples of 9% of patients (10,11). The rate of occult
malignancy detected in the NAC in mastectomy specimens
has varied widely with studies reporting an incidence of
1‑31% (12‑16). Over the years, a number of prospective and
retrospective studies have demonstrated a cancer recurrence
rate in the NAC of up to 2%, with local recurrence rates
ranging from 1‑6% (17‑19). A more recent meta‑analysis
comparing NSM to skin‑sparing mastectomy (SSM) and/or
modified radical mastectomy (MRM) identified no difference
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in overall survival, disease free survival or local recurrence
amongst the groups in properly selected patients with early
stage breast cancer (20).
Overall complication rates for NSM have been reported to
be as high as 60% in certain older studies, with more recent
data suggesting complication rates of 16‑22% (21‑22). In a
2003 study published by Gerber et al (19) the complication rate
of NSM was compared with SSM and MRM and the overall
complication rates were 20, 20, and 18% respectively. Similar
findings have been reported in more recent retrospective
studies comparing NSM with SSM (16,21). With comparable
complication and recurrence rates to SSM, more surgeons are
offering NSM to patients as a more cosmetically appealing
alternative.
The current study was undertaken to evaluate the outcomes
of patients undergoing NSMs at a single, large university
hospital. Specifically, complication rates and tumor recurrence
were studied.
Patients and methods
Patients. A prospectively maintained database of all surgical
patients with breast cancer treated between September 2008
and June 2014 was queried following approval from the
Washington University Institutional Review Board. A retrospective chart review was then undertaken for all patients
who had undergone an NSM performed by one of two breast
surgical oncologists with reconstruction performed by one of
two plastic surgeons. Charts were reviewed for patient demographics, including age, body mass index (BMI) and smoking
status. In those patients who underwent NSMs due to cancer,
tumor characteristics were also recorded, including tumor
size and nipple to tumor distance as well as tumor recurrence.
All patients were required to have a tumor to nipple distance
of >2 cm to be eligible for nipple‑sparing mastectomy at our
institution. The incision utilized, as well as the type of reconstruction undertaken were also evaluated. For all patients,
any complications occurring within 30 days of surgery were
documented, including any additional surgical procedures that
were performed.
Statistical analysis. Statistical analysis was performed
utilizing Fisher's exact test for categorical variables and
student's unpaired t‑test for continuous variables utilizing
SPSS software version 22 (IBM SPSS, Armonk, NY, USA).
P<0.05 was considered to indicate a statistically significant
difference.
Results
Patient demographics. In the 6‑year study period, 110 patients
underwent 197 NSMs. Twenty‑three (20.9%) patients had a
unilateral NSM, while 87 (79.1%) went on to have bilateral
NSMs. Of the 197 procedures performed, 124 (62.9%) were
prophylactic and 73 (37.1%) were completed for cancer. Of the
patients presenting with a breast cancer diagnosis, 25 (34.2%)
had ductal carcinoma in situ (DCIS), 32 (43.8%) were TNM
Stage I, 14 (19.2%) were TNM Stage II and 2 (2.8%) were TNM
Stage III. Nine (8%) patients underwent neoadjuvant chemotherapy, 17 (15.5%) were treated with adjuvant chemotherapy

and 3 (2.7%) underwent neoadjuvant and adjuvant chemotherapy. Two (1.8%) patients had undergone previous breast
conserving therapy with radiation therapy. Ten (9%) patients
underwent adjuvant chest wall radiation due to positive or
close (<1 mm) margins or lymph node involvement on final
pathology results.
The mean age of all patients undergoing surgery was
44.4 years (range, 20‑77). Overall, the patients in the current
study were at a healthy weight with an average BMI of 24, with
a BMI range of 18‑47. Breast weight was only documented
for 106 specimens, with a mean weight of 475.5 g (range,
124.1‑1,625.0 g). Thirteen (11.8%) of the patients studied were
active smokers at the time of surgery.
Complications. The overall complication rate in this study was
17.3% (34/197; Table I). There was no statistically significant
difference in complication rates based on patient age, BMI or
breast weight. However, those patients who had complications
were more likely to be smokers (26.5%) compared to patients
without any complications (8.6%; P<0.05). Four of the patients
who were smokers developed bilateral complications of infection and nipple necrosis. Thirteen patients underwent removal
of their implant or tissue expander due to a complication and
this was more common in smokers (25.0%) than nonsmokers
(4.6%; P<0.05).
There was no difference in the rate of complications,
whether the operation was performed prophylactically or as
part of breast cancer treatment (Table I). We considered a positive nipple margin to be a complication; therefore those patients
with a closer tumor to nipple distance on final pathology had
a significantly higher complication rate (Table I). Of the
patients with complications, 5 (14.7%) had undergone either
prior chest wall radiation or adjuvant radiation compared with
only 7 (4.3%) patients without complications (P<0.05). The
most common complications were skin flap or nipple necrosis
(12/34) and infection (11/34) (Table II). Five occurrences of
necrosis required NAC reconstruction, 3 instances were extensive necrosis necessitating implant removal and an additional
2 required surgical revision of the incision. Of the 11 infections occurring in the 30‑day postoperative period, 9 required
removal of the implant and 1 patient required surgical revision
of their wound. Five hematomas occurred postoperatively
with 3 requiring surgery for evacuation of the hematoma and
1 necessitating implant removal. A single seroma occurred in
the 30‑day postoperative period, which was treated with needle
aspiration. One patient developed flash pulmonary edema in
the immediate postoperative period but had had bilateral NSMs
and therefore was considered to have had two complications.
Surgical technique. Twenty‑seven (13.7%) NSMs were
completed via a circumareolar approach, 71 (36%) via a lateral
breast incision and 99 (50.3%) utilizing an inframammary
incision. There was no difference in overall complication rates
among the three incision types utilized (Table I). However,
when evaluating the 9 complications that resulted in loss of the
NAC, there was a significant difference amongst the 3 incision
types utilized (Table III). Seven of the 9 (77.8%) instances
of NAC loss occurred following the use of a circumareolar
incision compared to 1 (11.1%) loss each with the lateral and
inframammary approaches (P<0.05). The removal of the
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Table I. Comparison of demographics, tumor characteristics and surgical data of patients undergoing nipple‑sparing mastectomies
with and without subsequent complications.

Patient age, years (range)
BMI (range)
Smoker (%)
Prophylactic surgery (%)
Stage (%)
0
I
II
III
Breast weight, g (range)a
Tumor size, cm (range)b
Tumor to nipple distance, cm (range)c
Chest wall radiation
Incision utilized
Circumareolar
Lateral
Inframammary
Reconstruction
Tissue expander
Direct to implant

No complications (n=163)

Complications (n=34)

P‑value

44.1 (25‑77)
25.2 (19.9‑31.2)
14 (8.6)
105 (64.4)

43.6 (20‑72)
23.7 (17.9‑47.2)
9 (26.5)
19 (55.8)

NS
NS
<0.01
NS

21 (12.9)
26 (16)
10 (6.1)
1 (0.6)
458 (124‑1625)
1.5 (0‑6)
5.87 (2.93‑10.7)
7 (4.3)

4 (11.8)
6 (17.6)
4 (11.8)
1 (3)
545 (170‑836)
1.0 (0‑1.05)
5.23 (0‑8.51)
5 (14.7)

NS
NS
NS
NS
NS
NS
<0.05
<0.05

19 (11.7)
62 (38.0)
82 (50.3)

8 (23.5)
9 (26.5)
17 (50)

NS
NS
NS

18 (52.9)
16 (47.1)

88 (54)
75 (46)

NS
NS

Patient data not available for 78 patients without complications and 13 patients with complications. bPatient data not available for 3 patients
without complications and 1 patient with complications. cPatient data not available for 19 patients without complications and 7 patients with
complications. P‑values calculated using Student's unpaired t‑test and Fisher's exact test. NS, non‑significant.
a

Table II. All complications (n=34) and additional surgical procedures performed to correct the associated complication.
Complication type

Number of complications

Positive nipple margin
3
Hematoma
5
Infection
11
Necrosis
12
		
Seroma
1
Flash pulmonary edema
2

Additional procedures required (n)
Removal of NAC (3)
Evacuation (3), implant removal (1)
Implant removal (9), wound revision (1)
NAC reconstruction (5), implant removal (3),
revision of incision (2)
Aspiration
None

NAC, nipple areolar complex.

NAC that occurred after both a lateral and inframammary
approach was due to DCIS behind the nipple, whereas only
1 NAC was removed following a circumareolar incision
due to a positive nipple margin. The type of reconstruction
performed did not affect complication rates (Table I). Overall,
106 (53.8%) patients underwent reconstruction with tissue
expander placement and 91 (46.2%) received direct‑to‑implant
based reconstruction. There was no difference in complication rate among patients receiving a tissue expander (16.9%)
and direct implant (17.6%) (P>0.05). However, a significantly

larger percentage of patients receiving a direct implant (10.9%)
underwent implant removal due to a complication than those
with placement of a tissue expander (2.8%; P<0.05).
Outcomes. In the first 3 years of the study, 44 NSMs were
performed with 9 (20.5%) complications, compared with a
complication rate of 16.3% (25/153) in the final 3 years of the
study (P>0.05). The complication rate has steadily declined,
with only 5/37 (13.5%) patients experiencing a complication
occurring in the most recent six months of the study.
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Table III. Comparison of the incision utilized and the rate of
NAC loss.
Incision utilized
Circumareolar, n (%)
Lateral, n (%)
Inframammary, n (%)

Loss of NAC (n=9)

P‑value

7 (77.8)
1 (11.1)
1 (11.1)

<0.05

P‑value calculated using Fisher's exact test. NAC, nipple areolar
complex.

Follow‑up ranged between 3 months and 6 years, and
only one (1.4%) patient in the cohort who underwent an NSM
for cancer ultimately developed a recurrence. This occurred
in a patient with a T1N0 tumor, 4.75 cm from the NAC who
developed a chest wall recurrence. There were no instances of
tumor recurrence within the NAC in the current study.
Discussion
The rate of local recurrence in numerous studies of patients
undergoing an NSM varies, ranging from 0‑25.7% (18,19,23,24).
In the studies demonstrating rates of local recurrence >10%,
cancer recurrence in the lymph nodes was included in the
rate (19,24). Gerber et al (19) evaluated 246 patients with an
indication for MRM who were treated with MRM, SSM or
NSM with axillary lymph node dissection, identifying no
differences in the rates of local recurrence amongst the three
groups after a mean follow‑up period of 101 months. More
recent studies have demonstrated much lower local recurrence
rates, similar to the present findings (16,24). An analysis of
1,006 procedures from the Italian National database of NSM,
the local regional recurrence rate was 2.9% with a recurrence
rate in the NAC of 0.7% (25). In the present study, a single
recurrence occurred, yielding a local recurrence rate of 1.4%.
This was a chest wall recurrence in a patient with stage I (T1N0)
cancer who did not require adjuvant chemotherapy or radiation
following NSM. No patients presented with recurrence in the
NAC during the time period studied.
In order to decrease the likelihood of cancer involvement
of the NAC, numerous studies have recommended that the
tumor to NAC distance on pre‑operative imaging be no closer
than 2 cm (23,26‑28). Tumors found to be closer than 2 cm to
the NAC are considered to be a relative contraindication to
pursuing NSM. The lower local recurrence rate in the current
study is likely due in large part to patient selection, as there
was a requirement that all imaging demonstrate a distance
>2 cm between the tumor and the NAC. A previous study by
Tang et al (29) evaluated their group's experience with positive
nipple margins and management, including excision of only
the nipple with retention of the areola, and identified that at a
36‑month median follow‑up, no recurrences occurred in the
nipple/NAC. This may expand the indications for NSM in the
future.
The complication rate in the present study was 17.3%,
which is comparable with the reported literature (21,25,30,31).
In the current study, those patients with a closer tumor to

nipple distance had a higher complication rate. Any patient
requiring excision of the nipple‑areolar complex (NAC)
for any reason was considered to have had a complication.
Therefore a higher complication rate associated with a close
tumor to nipple distance is attributed to the three patients who
had excision of the NAC for a final positive nipple margin with
involvement of DCIS. The closest tumor to nipple margin,
without a positive margin or complication, in this study was
found to be 2.93 cm.
Although the rate of overall complications was similar
from 2008‑2011 and 2012‑2014, when examining the data
for 2014, as experience with the operation has increased the
complication rate has decreased to 13.5%. As this is becoming
a more common option for patients, the present study anticipates a further decline in complications.
Smoking is established to increase complication rates in
breast surgery (5,31‑36). In a prospective study published by
Matsen et al (33) examining skin flap necrosis rates following
any mastectomy with reconstruction, 14% of patients had
some level of skin flap necrosis (33). Using univariate analysis,
smoking was revealed to be a significant factor in necrosis
rates (32). Similarly, in a study published in 2014, 6% of
patients undergoing NSM were found to be smokers, and had
an odds ratio of 3.3 for any complications compared with
non‑smokers (31). This trend was also evident in the present
study, with patients who were smokers at the time of NSM
having significantly more complications than non‑smokers
and requiring removal of their implants or tissue expanders
due to these complications.
One of the most well‑described complications to occur
after an NSM is skin or nipple necrosis, which at times necessitates removal of the NAC. In the majority of contemporary
studies, the necrosis rate has been found to be between 0 and
7% (21,22,25,31). In the current study the total necrosis rate
was 6%, with 5 (2.5%) patients requiring removal and reconstruction of the NAC due to the extent of necrosis.
When NSMs were first being performed at the Washington
University School of Medicine, one of three incision types
was utilized: Circumareolar (which encompassed a portion
of the NAC border), lateral radial and inframammary. The
circumareolar approach was replaced by the lateral radial or
inframammary incisions, as there was significantly less loss of
the NAC when the incision did not involve the NAC. This has
been demonstrated by numerous other studies (28,34,37). In
a 2014 retrospective review of 500 NSMs, patients with incisions encompassing the NAC had a complication rate of 21.1%
compared to 8.5% when the inframammary incision was
used (31). A meta‑analysis of 48 studies published between
1970 and 2013 evaluated whether incision type led to an
increase in nipple necrosis, and revealed that a circumareolar
incision yielded a 17.81% necrosis rate, whereas while radial/
lateral and inframammary incisions had necrosis rates of 8.83
and 9.09%, respectively (21). Due to the increased number of
complications and rate of nipple loss with a circumareolar
approach in both the literature and in the present study, this
has been abandoned at Washington University School of
Medicine and NSMs are now performed through a lateral or
inframammary incision only.
Historically, patients who underwent implant‑based reconstruction following NSM had tissue expanders placed at the

MOLECULAR AND CLINICAL ONCOLOGY 6: 737-742, 2017

time of mastectomy, however immediate reconstruction with
a silicone or saline implant following NSM has become more
widely accepted in recent years. In a 2010 prospective study
of 214 consecutive NSMs with immediate silicone implant
reconstruction, the overall complication rate was 16% with 6%
requiring explantation of the prostheses due to the complication (22). In 2012 the present study began performing NSM
with direct‑to‑implant reconstruction and in the study period
identified no difference in complication rates when a permanent
implant was placed at the time of mastectomy in lieu of a tissue
expander; however, more patients with direct implant‑based
reconstruction required removal of their implants.
There are limitations to the present study, as it was a retrospective chart review and certain medical data was missing
or incomplete. For example, breast weight was only recorded
for 106 breast specimens and therefore the current study was
unable to delineate whether larger breast size increases complication rates. Although this is a retrospective study, it provides
additional data regarding the oncologic safety and low complication rate of NSMs. It is unlikely that a randomized controlled
trial may be offered to patients comparing NSM to SSM and
MRM, as patients who are candidates for a NSM would not
want to be randomized to a less cosmetically pleasing surgery.
In conclusion, the present study adds to the growing
literature demonstrating the oncologic safety of NSMs with
a local recurrence rate of 1.4% in properly selected patients
with tumor to nipple distance >2 cm. Additionally, the current
study also demonstrated a low complication rate, including
a low rate of nipple‑areolar loss with a lateral or inframammary incision. These results further demonstrate that NSMs
are safe and do not comprise oncologic outcomes or increase
complication rates.
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